
Allied Health Virtual Journal Club Online: Late Breaking SMART and a Look at Biologics Course
English
Recorded Courses
hosted by American Academy of Allergy Asthma & Immunology (AAAAI)
hosted by American Academy of Allergy Asthma & Immunology (AAAAI)
attend it anywhere online
category
Medicine
Allergy & Immunology
price
On Book
Allied Health Virtual Journal Club Online: Late Breaking SMART and a Look at Biologics is organized by American Academy of Allergy Asthma & Immunology (AAAAI).,,Course opens: 08/25/2022,Course expires: 06/30/2023,,Description:,In the Allied Health Virtual Journal Club online, moderators and presenters facilitate an interactive discussion on two journal articles relevant to Allied Health providers and other professionals in the allergy/immunology field. Advances in the management of asthma in adults are soaring. New global guidelines no longer recommend using short-acting beta agonist alone to treat adults and adolescents with asthma. Expansion of specific biologics now include a pediatric population. Dr. Leonard Bacharier, MD FAAAAI, a well-published, renowned asthma expert, will serve as our summer Allied Health Journal Club discussion leader, with Dr. Karen Gregory, DNP APRN-BC RRT AE-C moderating. We will review the two articles listed below, which were co-authored by Dr. Bacharier. Participants will have the opportunity to discuss the heterogenic nature of asthma pathophysiology and the importance of personalized care and evidence-based treatment plans, including SMART (single maintenance and reliever therapy).,,Learning Objectives:,Upon completion of this activity, participants should be able to:,• Discuss the differences between current asthma treatment regimens containing an anti-inflammatory reliever (AIR) and single-inhaler maintenance and reliever therapy (SMART),• Identify key recommendations from the Global Initiative for Asthma 2021 strategry report,• Define characteristics of the biologics that are FDA-approved for the treatment of moderate-to-severe persistent asthma with a T2-high phenotype,• Recognize the mechanisms of action, specific conditions, benefits and side effects of each of the approved biological therapies for asthma